Global Targeted Antitumor Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 141
Published Date: 11 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Targeted Antitumor Drugs market size was valued at USD 36850 million in 2023 and is forecast to a readjusted size of USD 58750 million by 2030 with a CAGR of 6.9% during review period.
Targeted antitumor drugs use specific structural molecules of tumor tissues or cells as targets to achieve the purpose of directly killing tumor cells, and have the advantages of high specificity, high selectivity, light side reactions and high efficacy/toxicity ratio compared with chemotherapy drugs
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Targeted Antitumor Drugs industry chain, the market status of Lung Cancer (Injection, Tablet), Lymphoma (Injection, Tablet), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Targeted Antitumor Drugs.
Regionally, the report analyzes the Targeted Antitumor Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Targeted Antitumor Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Targeted Antitumor Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Targeted Antitumor Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Injection, Tablet).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Targeted Antitumor Drugs market.
Regional Analysis: The report involves examining the Targeted Antitumor Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Targeted Antitumor Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Targeted Antitumor Drugs:
Company Analysis: Report covers individual Targeted Antitumor Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Targeted Antitumor Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Lung Cancer, Lymphoma).
Technology Analysis: Report covers specific technologies relevant to Targeted Antitumor Drugs. It assesses the current state, advancements, and potential future developments in Targeted Antitumor Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Targeted Antitumor Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Targeted Antitumor Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Injection
Tablet
Others
Market segment by Application
Lung Cancer
Lymphoma
Breast Cancer
Leukaemia
Prostate Cancer
Multiple Bone Marrow Cancer
Others
Major players covered
Roche
Celgene
Novartis
Johnson & Johnson
Lilly
AstraZeneca plc.
Betta Pharmaceuticals
Shanghai Henlius Biopharmaceutical
Innovent Biologics
Nanjing Shunxin Pharmaceuticals
CSPC OUYI Pharmaceutical
Qilu Pharmaceutical
Shenzhen Salubris Pharmaceuticals
Yaopharma
Lianyungang Runzhong Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Targeted Antitumor Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Targeted Antitumor Drugs, with price, sales, revenue and global market share of Targeted Antitumor Drugs from 2019 to 2024.
Chapter 3, the Targeted Antitumor Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Targeted Antitumor Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Targeted Antitumor Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Targeted Antitumor Drugs.
Chapter 14 and 15, to describe Targeted Antitumor Drugs sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Targeted Antitumor Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Targeted Antitumor Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Injection
1.3.3 Tablet
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Targeted Antitumor Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Lung Cancer
1.4.3 Lymphoma
1.4.4 Breast Cancer
1.4.5 Leukaemia
1.4.6 Prostate Cancer
1.4.7 Multiple Bone Marrow Cancer
1.4.8 Others
1.5 Global Targeted Antitumor Drugs Market Size & Forecast
1.5.1 Global Targeted Antitumor Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Targeted Antitumor Drugs Sales Quantity (2019-2030)
1.5.3 Global Targeted Antitumor Drugs Average Price (2019-2030)
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Targeted Antitumor Drugs Product and Services
2.1.4 Roche Targeted Antitumor Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments/Updates
2.2 Celgene
2.2.1 Celgene Details
2.2.2 Celgene Major Business
2.2.3 Celgene Targeted Antitumor Drugs Product and Services
2.2.4 Celgene Targeted Antitumor Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Celgene Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Targeted Antitumor Drugs Product and Services
2.3.4 Novartis Targeted Antitumor Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments/Updates
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Targeted Antitumor Drugs Product and Services
2.4.4 Johnson & Johnson Targeted Antitumor Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Johnson & Johnson Recent Developments/Updates
2.5 Lilly
2.5.1 Lilly Details
2.5.2 Lilly Major Business
2.5.3 Lilly Targeted Antitumor Drugs Product and Services
2.5.4 Lilly Targeted Antitumor Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Lilly Recent Developments/Updates
2.6 AstraZeneca plc.
2.6.1 AstraZeneca plc. Details
2.6.2 AstraZeneca plc. Major Business
2.6.3 AstraZeneca plc. Targeted Antitumor Drugs Product and Services
2.6.4 AstraZeneca plc. Targeted Antitumor Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 AstraZeneca plc. Recent Developments/Updates
2.7 Betta Pharmaceuticals
2.7.1 Betta Pharmaceuticals Details
2.7.2 Betta Pharmaceuticals Major Business
2.7.3 Betta Pharmaceuticals Targeted Antitumor Drugs Product and Services
2.7.4 Betta Pharmaceuticals Targeted Antitumor Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Betta Pharmaceuticals Recent Developments/Updates
2.8 Shanghai Henlius Biopharmaceutical
2.8.1 Shanghai Henlius Biopharmaceutical Details
2.8.2 Shanghai Henlius Biopharmaceutical Major Business
2.8.3 Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Product and Services
2.8.4 Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Shanghai Henlius Biopharmaceutical Recent Developments/Updates
2.9 Innovent Biologics
2.9.1 Innovent Biologics Details
2.9.2 Innovent Biologics Major Business
2.9.3 Innovent Biologics Targeted Antitumor Drugs Product and Services
2.9.4 Innovent Biologics Targeted Antitumor Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Innovent Biologics Recent Developments/Updates
2.10 Nanjing Shunxin Pharmaceuticals
2.10.1 Nanjing Shunxin Pharmaceuticals Details
2.10.2 Nanjing Shunxin Pharmaceuticals Major Business
2.10.3 Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Product and Services
2.10.4 Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Nanjing Shunxin Pharmaceuticals Recent Developments/Updates
2.11 CSPC OUYI Pharmaceutical
2.11.1 CSPC OUYI Pharmaceutical Details
2.11.2 CSPC OUYI Pharmaceutical Major Business
2.11.3 CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Product and Services
2.11.4 CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 CSPC OUYI Pharmaceutical Recent Developments/Updates
2.12 Qilu Pharmaceutical
2.12.1 Qilu Pharmaceutical Details
2.12.2 Qilu Pharmaceutical Major Business
2.12.3 Qilu Pharmaceutical Targeted Antitumor Drugs Product and Services
2.12.4 Qilu Pharmaceutical Targeted Antitumor Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Qilu Pharmaceutical Recent Developments/Updates
2.13 Shenzhen Salubris Pharmaceuticals
2.13.1 Shenzhen Salubris Pharmaceuticals Details
2.13.2 Shenzhen Salubris Pharmaceuticals Major Business
2.13.3 Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Product and Services
2.13.4 Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Shenzhen Salubris Pharmaceuticals Recent Developments/Updates
2.14 Yaopharma
2.14.1 Yaopharma Details
2.14.2 Yaopharma Major Business
2.14.3 Yaopharma Targeted Antitumor Drugs Product and Services
2.14.4 Yaopharma Targeted Antitumor Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Yaopharma Recent Developments/Updates
2.15 Lianyungang Runzhong Pharmaceutical
2.15.1 Lianyungang Runzhong Pharmaceutical Details
2.15.2 Lianyungang Runzhong Pharmaceutical Major Business
2.15.3 Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Product and Services
2.15.4 Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Lianyungang Runzhong Pharmaceutical Recent Developments/Updates
3.1 Global Targeted Antitumor Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Targeted Antitumor Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Targeted Antitumor Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Targeted Antitumor Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Targeted Antitumor Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Targeted Antitumor Drugs Manufacturer Market Share in 2023
3.5 Targeted Antitumor Drugs Market: Overall Company Footprint Analysis
3.5.1 Targeted Antitumor Drugs Market: Region Footprint
3.5.2 Targeted Antitumor Drugs Market: Company Product Type Footprint
3.5.3 Targeted Antitumor Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Targeted Antitumor Drugs Market Size by Region
4.1.1 Global Targeted Antitumor Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Targeted Antitumor Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Targeted Antitumor Drugs Average Price by Region (2019-2030)
4.2 North America Targeted Antitumor Drugs Consumption Value (2019-2030)
4.3 Europe Targeted Antitumor Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Targeted Antitumor Drugs Consumption Value (2019-2030)
4.5 South America Targeted Antitumor Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Targeted Antitumor Drugs Consumption Value (2019-2030)
5.1 Global Targeted Antitumor Drugs Sales Quantity by Type (2019-2030)
5.2 Global Targeted Antitumor Drugs Consumption Value by Type (2019-2030)
5.3 Global Targeted Antitumor Drugs Average Price by Type (2019-2030)
6.1 Global Targeted Antitumor Drugs Sales Quantity by Application (2019-2030)
6.2 Global Targeted Antitumor Drugs Consumption Value by Application (2019-2030)
6.3 Global Targeted Antitumor Drugs Average Price by Application (2019-2030)
7.1 North America Targeted Antitumor Drugs Sales Quantity by Type (2019-2030)
7.2 North America Targeted Antitumor Drugs Sales Quantity by Application (2019-2030)
7.3 North America Targeted Antitumor Drugs Market Size by Country
7.3.1 North America Targeted Antitumor Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Targeted Antitumor Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Targeted Antitumor Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Targeted Antitumor Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Targeted Antitumor Drugs Market Size by Country
8.3.1 Europe Targeted Antitumor Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Targeted Antitumor Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Targeted Antitumor Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Targeted Antitumor Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Targeted Antitumor Drugs Market Size by Region
9.3.1 Asia-Pacific Targeted Antitumor Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Targeted Antitumor Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Targeted Antitumor Drugs Sales Quantity by Type (2019-2030)
10.2 South America Targeted Antitumor Drugs Sales Quantity by Application (2019-2030)
10.3 South America Targeted Antitumor Drugs Market Size by Country
10.3.1 South America Targeted Antitumor Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Targeted Antitumor Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Targeted Antitumor Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Targeted Antitumor Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Targeted Antitumor Drugs Market Size by Country
11.3.1 Middle East & Africa Targeted Antitumor Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Targeted Antitumor Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Targeted Antitumor Drugs Market Drivers
12.2 Targeted Antitumor Drugs Market Restraints
12.3 Targeted Antitumor Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Targeted Antitumor Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Targeted Antitumor Drugs
13.3 Targeted Antitumor Drugs Production Process
13.4 Targeted Antitumor Drugs Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Targeted Antitumor Drugs Typical Distributors
14.3 Targeted Antitumor Drugs Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Targeted Antitumor Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Targeted Antitumor Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Targeted Antitumor Drugs Product and Services
Table 6. Roche Targeted Antitumor Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Roche Recent Developments/Updates
Table 8. Celgene Basic Information, Manufacturing Base and Competitors
Table 9. Celgene Major Business
Table 10. Celgene Targeted Antitumor Drugs Product and Services
Table 11. Celgene Targeted Antitumor Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Celgene Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis Targeted Antitumor Drugs Product and Services
Table 16. Novartis Targeted Antitumor Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Novartis Recent Developments/Updates
Table 18. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 19. Johnson & Johnson Major Business
Table 20. Johnson & Johnson Targeted Antitumor Drugs Product and Services
Table 21. Johnson & Johnson Targeted Antitumor Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Johnson & Johnson Recent Developments/Updates
Table 23. Lilly Basic Information, Manufacturing Base and Competitors
Table 24. Lilly Major Business
Table 25. Lilly Targeted Antitumor Drugs Product and Services
Table 26. Lilly Targeted Antitumor Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Lilly Recent Developments/Updates
Table 28. AstraZeneca plc. Basic Information, Manufacturing Base and Competitors
Table 29. AstraZeneca plc. Major Business
Table 30. AstraZeneca plc. Targeted Antitumor Drugs Product and Services
Table 31. AstraZeneca plc. Targeted Antitumor Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. AstraZeneca plc. Recent Developments/Updates
Table 33. Betta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Betta Pharmaceuticals Major Business
Table 35. Betta Pharmaceuticals Targeted Antitumor Drugs Product and Services
Table 36. Betta Pharmaceuticals Targeted Antitumor Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Betta Pharmaceuticals Recent Developments/Updates
Table 38. Shanghai Henlius Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Shanghai Henlius Biopharmaceutical Major Business
Table 40. Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Product and Services
Table 41. Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Shanghai Henlius Biopharmaceutical Recent Developments/Updates
Table 43. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 44. Innovent Biologics Major Business
Table 45. Innovent Biologics Targeted Antitumor Drugs Product and Services
Table 46. Innovent Biologics Targeted Antitumor Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Innovent Biologics Recent Developments/Updates
Table 48. Nanjing Shunxin Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Nanjing Shunxin Pharmaceuticals Major Business
Table 50. Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Product and Services
Table 51. Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Nanjing Shunxin Pharmaceuticals Recent Developments/Updates
Table 53. CSPC OUYI Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. CSPC OUYI Pharmaceutical Major Business
Table 55. CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Product and Services
Table 56. CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. CSPC OUYI Pharmaceutical Recent Developments/Updates
Table 58. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Qilu Pharmaceutical Major Business
Table 60. Qilu Pharmaceutical Targeted Antitumor Drugs Product and Services
Table 61. Qilu Pharmaceutical Targeted Antitumor Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Qilu Pharmaceutical Recent Developments/Updates
Table 63. Shenzhen Salubris Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Shenzhen Salubris Pharmaceuticals Major Business
Table 65. Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Product and Services
Table 66. Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Shenzhen Salubris Pharmaceuticals Recent Developments/Updates
Table 68. Yaopharma Basic Information, Manufacturing Base and Competitors
Table 69. Yaopharma Major Business
Table 70. Yaopharma Targeted Antitumor Drugs Product and Services
Table 71. Yaopharma Targeted Antitumor Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Yaopharma Recent Developments/Updates
Table 73. Lianyungang Runzhong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Lianyungang Runzhong Pharmaceutical Major Business
Table 75. Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Product and Services
Table 76. Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Lianyungang Runzhong Pharmaceutical Recent Developments/Updates
Table 78. Global Targeted Antitumor Drugs Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 79. Global Targeted Antitumor Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 80. Global Targeted Antitumor Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 81. Market Position of Manufacturers in Targeted Antitumor Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 82. Head Office and Targeted Antitumor Drugs Production Site of Key Manufacturer
Table 83. Targeted Antitumor Drugs Market: Company Product Type Footprint
Table 84. Targeted Antitumor Drugs Market: Company Product Application Footprint
Table 85. Targeted Antitumor Drugs New Market Entrants and Barriers to Market Entry
Table 86. Targeted Antitumor Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Targeted Antitumor Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 88. Global Targeted Antitumor Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 89. Global Targeted Antitumor Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 90. Global Targeted Antitumor Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 91. Global Targeted Antitumor Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 92. Global Targeted Antitumor Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 93. Global Targeted Antitumor Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 94. Global Targeted Antitumor Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 95. Global Targeted Antitumor Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Global Targeted Antitumor Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Global Targeted Antitumor Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 98. Global Targeted Antitumor Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 99. Global Targeted Antitumor Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 100. Global Targeted Antitumor Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 101. Global Targeted Antitumor Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 102. Global Targeted Antitumor Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 103. Global Targeted Antitumor Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 104. Global Targeted Antitumor Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 105. North America Targeted Antitumor Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 106. North America Targeted Antitumor Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 107. North America Targeted Antitumor Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 108. North America Targeted Antitumor Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 109. North America Targeted Antitumor Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 110. North America Targeted Antitumor Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 111. North America Targeted Antitumor Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 112. North America Targeted Antitumor Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Europe Targeted Antitumor Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 114. Europe Targeted Antitumor Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 115. Europe Targeted Antitumor Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 116. Europe Targeted Antitumor Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 117. Europe Targeted Antitumor Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 118. Europe Targeted Antitumor Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 119. Europe Targeted Antitumor Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Europe Targeted Antitumor Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Asia-Pacific Targeted Antitumor Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 122. Asia-Pacific Targeted Antitumor Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 123. Asia-Pacific Targeted Antitumor Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 124. Asia-Pacific Targeted Antitumor Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 125. Asia-Pacific Targeted Antitumor Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 126. Asia-Pacific Targeted Antitumor Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 127. Asia-Pacific Targeted Antitumor Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 128. Asia-Pacific Targeted Antitumor Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 129. South America Targeted Antitumor Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 130. South America Targeted Antitumor Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 131. South America Targeted Antitumor Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 132. South America Targeted Antitumor Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 133. South America Targeted Antitumor Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 134. South America Targeted Antitumor Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 135. South America Targeted Antitumor Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 136. South America Targeted Antitumor Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 137. Middle East & Africa Targeted Antitumor Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 138. Middle East & Africa Targeted Antitumor Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 139. Middle East & Africa Targeted Antitumor Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 140. Middle East & Africa Targeted Antitumor Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 141. Middle East & Africa Targeted Antitumor Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 142. Middle East & Africa Targeted Antitumor Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 143. Middle East & Africa Targeted Antitumor Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 144. Middle East & Africa Targeted Antitumor Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 145. Targeted Antitumor Drugs Raw Material
Table 146. Key Manufacturers of Targeted Antitumor Drugs Raw Materials
Table 147. Targeted Antitumor Drugs Typical Distributors
Table 148. Targeted Antitumor Drugs Typical Customers
List of Figures
Figure 1. Targeted Antitumor Drugs Picture
Figure 2. Global Targeted Antitumor Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Targeted Antitumor Drugs Consumption Value Market Share by Type in 2023
Figure 4. Injection Examples
Figure 5. Tablet Examples
Figure 6. Others Examples
Figure 7. Global Targeted Antitumor Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Targeted Antitumor Drugs Consumption Value Market Share by Application in 2023
Figure 9. Lung Cancer Examples
Figure 10. Lymphoma Examples
Figure 11. Breast Cancer Examples
Figure 12. Leukaemia Examples
Figure 13. Prostate Cancer Examples
Figure 14. Multiple Bone Marrow Cancer Examples
Figure 15. Others Examples
Figure 16. Global Targeted Antitumor Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Targeted Antitumor Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Targeted Antitumor Drugs Sales Quantity (2019-2030) & (K Units)
Figure 19. Global Targeted Antitumor Drugs Average Price (2019-2030) & (US$/Unit)
Figure 20. Global Targeted Antitumor Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 21. Global Targeted Antitumor Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 22. Producer Shipments of Targeted Antitumor Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 23. Top 3 Targeted Antitumor Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Top 6 Targeted Antitumor Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Global Targeted Antitumor Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 26. Global Targeted Antitumor Drugs Consumption Value Market Share by Region (2019-2030)
Figure 27. North America Targeted Antitumor Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. Europe Targeted Antitumor Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Asia-Pacific Targeted Antitumor Drugs Consumption Value (2019-2030) & (USD Million)
Figure 30. South America Targeted Antitumor Drugs Consumption Value (2019-2030) & (USD Million)
Figure 31. Middle East & Africa Targeted Antitumor Drugs Consumption Value (2019-2030) & (USD Million)
Figure 32. Global Targeted Antitumor Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Targeted Antitumor Drugs Consumption Value Market Share by Type (2019-2030)
Figure 34. Global Targeted Antitumor Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 35. Global Targeted Antitumor Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 36. Global Targeted Antitumor Drugs Consumption Value Market Share by Application (2019-2030)
Figure 37. Global Targeted Antitumor Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 38. North America Targeted Antitumor Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Targeted Antitumor Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 40. North America Targeted Antitumor Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 41. North America Targeted Antitumor Drugs Consumption Value Market Share by Country (2019-2030)
Figure 42. United States Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Canada Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Mexico Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Europe Targeted Antitumor Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 46. Europe Targeted Antitumor Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 47. Europe Targeted Antitumor Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 48. Europe Targeted Antitumor Drugs Consumption Value Market Share by Country (2019-2030)
Figure 49. Germany Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. France Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. United Kingdom Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Russia Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Italy Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Asia-Pacific Targeted Antitumor Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 55. Asia-Pacific Targeted Antitumor Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 56. Asia-Pacific Targeted Antitumor Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 57. Asia-Pacific Targeted Antitumor Drugs Consumption Value Market Share by Region (2019-2030)
Figure 58. China Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Japan Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Korea Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. India Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Southeast Asia Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Australia Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. South America Targeted Antitumor Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 65. South America Targeted Antitumor Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 66. South America Targeted Antitumor Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 67. South America Targeted Antitumor Drugs Consumption Value Market Share by Country (2019-2030)
Figure 68. Brazil Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Argentina Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Middle East & Africa Targeted Antitumor Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 71. Middle East & Africa Targeted Antitumor Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 72. Middle East & Africa Targeted Antitumor Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 73. Middle East & Africa Targeted Antitumor Drugs Consumption Value Market Share by Region (2019-2030)
Figure 74. Turkey Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Egypt Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Saudi Arabia Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. South Africa Targeted Antitumor Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Targeted Antitumor Drugs Market Drivers
Figure 79. Targeted Antitumor Drugs Market Restraints
Figure 80. Targeted Antitumor Drugs Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Targeted Antitumor Drugs in 2023
Figure 83. Manufacturing Process Analysis of Targeted Antitumor Drugs
Figure 84. Targeted Antitumor Drugs Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Roche Celgene Novartis Johnson & Johnson Lilly AstraZeneca plc. Betta Pharmaceuticals Shanghai Henlius Biopharmaceutical Innovent Biologics Nanjing Shunxin Pharmaceuticals CSPC OUYI Pharmaceutical Qilu Pharmaceutical Shenzhen Salubris Pharmaceuticals Yaopharma Lianyungang Runzhong Pharmaceutical
Related Reports
03 Sep 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
